Tan BS, Lonic A, Morris MB, Rathjen PD, Rathjen J. The amino acid transporter SNAT2 mediates L-proline-induced differentiation of ES cells. Am J Physiol Cell Physiol 300: C1270-C1279, 2011. First published February 23, 2011 doi:10.1152/ajpcell.00235.2010There is an increasing appreciation that amino acids can act as signaling molecules in the regulation of cellular processes through modulation of intracellular cell signaling pathways. In culture, embryonic stem (ES) cells can be differentiated to a second, pluripotent cell population, early primitive ectoderm-like cells in response to biological activities within the conditioned medium MEDII. The amino acid L-proline has been identified as a component of MEDII required for ES cell differentiation. Here, we define the primary L-proline transporter on ES and early primitive ectoderm-like cells as sodium-coupled neutral amino acid transporter 2 (SNAT2). SNAT2 uptake of L-proline can be inhibited by the addition of millimolar concentrations of other substrates. The addition of excess amino acids was used to regulate the uptake of L-proline by ES cells, and the effect on differentiation was analyzed. The ability of SNAT2 substrates, but not other amino acids, to prevent changes in morphology, gene expression, and differentiation kinetics suggested that L-proline uptake through SNAT2 was required for ES cell differentiation. These data reveal an unexpected role for amino acid uptake and the amino acid transporter SNAT2 in regulation of pluripotent cells in culture and provides a number of specific, inexpensive, and nontoxic culture additives with the potential to improve the quality of ES cell culture. amino acids; amino acid transporters; embryonic stem cells; differentiation; primitive ectoderm IN RECENT YEARS, THE VIEW OF amino acids as simple nutrients has been challenged by an increasing number of reports that describe roles for amino acids as signaling molecules regulating a range of cellular processes, including neurotransmission (67), sensitization of inflammatory pain (6), regulation of gastric acid and pancreatic hormone in the gut and water excretion in the kidney (14), and maintenance of the bloodbrain barrier (29). Amino acids and amino acid transport have been shown to regulate cell growth and function through interaction with two established intracellular pathways: the amino acid response (AAR) pathway (41, 42) and the mammalian target of rapamycin (mTOR) signaling pathway (4, 49). For example, a low-capacity, high-affinity amino acid PAT (proton-assisted SLC36 amino acid transporter) receptor in D. melanogaster functions to regulate cell growth through modification of the activity of target of rapamycin (TOR) and signaling components of the insulin receptor pathway (21).
IN RECENT YEARS, THE VIEW OF amino acids as simple nutrients has been challenged by an increasing number of reports that describe roles for amino acids as signaling molecules regulating a range of cellular processes, including neurotransmission (67) , sensitization of inflammatory pain (6) , regulation of gastric acid and pancreatic hormone in the gut and water excretion in the kidney (14) , and maintenance of the bloodbrain barrier (29) . Amino acids and amino acid transport have been shown to regulate cell growth and function through interaction with two established intracellular pathways: the amino acid response (AAR) pathway (41, 42) and the mammalian target of rapamycin (mTOR) signaling pathway (4, 49) . For example, a low-capacity, high-affinity amino acid PAT (proton-assisted SLC36 amino acid transporter) receptor in D. melanogaster functions to regulate cell growth through modification of the activity of target of rapamycin (TOR) and signaling components of the insulin receptor pathway (21) .
Potential roles for amino acid regulation in the control of differentiation and cell fate choice in the early embryo have not been explored. This is despite the demonstrated involvement of amino acids in regulating blastocyst development (19, 20, 53, 54) , the dynamic temporal regulation of amino acid transporters during early embryonic development (3, 76) , the unusually high levels of some amino acids in fluids of the fallopian tube (24, 31) , and embryonic death early in development (5.5 days postcoitum) in mice deficient in mTOR (18, 56) . Death in these embryos results from a failure of the inner cell mass (ICM) and trophectoderm to proliferate, suggesting a requirement for mTOR signaling in these cell populations.
Our laboratory has recently reported the amino acid L-proline as the key bioactive component required for the differentiation of embryonic stem (ES) cells to a second pluripotent cell population, early primitive ectoderm-like (EPL) cells, in response to a conditioned medium, MEDII, in culture (78) . EPL cells share many properties with the embryonic epiblast or primitive ectoderm, including morphology, gene expression, differentiation potential, and response to cytokine signaling (46, 60, 61) . Addition of L-proline to ES cells at concentrations Ͼ100 M was accompanied by changes in cell morphology, gene expression, and differentiation kinetics, consistent with differentiation toward an EPL cell. The activity was specific to L-proline, as no other amino acid tested, nor any analogs of proline, exhibited the bioactivity. Activation of the mTOR signaling pathway was found to be necessary but not sufficient for L-proline activity; addition of other activators of the mTOR signaling pathway failed to alter the ES cell phenotype. These data suggest a role for amino acids, and particularly L-proline, in the regulation of pluripotence in culture (78) .
The activity of L-proline on ES cells was efficiently inhibited by addition of a molar excess of glycine, a property consistent with a requirement for an amino acid transporter and L-proline uptake in EPL cell formation (78) . The transport of L-proline into cells can be mediated by a number of different transporters (Table 1) . In this study, L-proline uptake assays suggest the primary mediator of L-proline uptake in ES cells as the sodiumcoupled neutral amino acid transporter 2 (SNAT2). L-Proline uptake by SNAT2 was inhibited by a number of amino acids, including glycine and L-serine, but not L-leucine (28, 52, 64, 70, 81) , consistent with the results in Washington et al. (78) . Furthermore, ES cell differentiation and adoption of EPL cell-like colony morphology, gene expression, and differentiation kinetics was prevented with the addition of an excess of amino acids recognized as substrates of SNAT2, such as (methylamino)isobutyric acid (MeAIB) and glycine, but not by amino acids not transported by SNAT2, such as ␥-aminobutyric acid (GABA) and L-lysine. These data suggest that the appropriate regulation of SNAT2 activity mediates the activity of L-proline on ES cells. The implication of L-proline and SNAT2 in ES cell differentiation may explain the cellular instability seen in mouse and human ES cells in culture, give a rationale for better media formulations for these cells, and, more broadly, provide a unique and tractable model system for understanding amino acid regulation of cells and characterizing the mechanisms by which amino acids exert control on intracellular pathways.
MATERIALS AND METHODS
Cell culture. D3 (15) and CGR8 (57) mouse-derived ES cell lines were maintained and differentiated to EPL cells in response to MEDII, essentially as described previously (63) . The ES cell medium used for this study was DMEM with high glucose (Life Technologies no. 11995-065) supplemented with 10% fetal calf serum (FCS; Life Technologies), 0.1 mM ␤-mercaptoethanol (Sigma-Aldrich), leukemia inhibitory factor (LIF; 1,000 -2,000 U/ml; manufactured in house), and penicillin/streptomycin (Life Technologies). The medium used for routine culture of ES cells or during the experimental procedures was not supplemented with any additional glutamine or nonessential amino acids. The final amino acid concentrations in ES cell medium are shown in Supplemental Table S1 . (The online version of this article contains supplemental data.) ES cells to be cultured in the presence of exogenous amino acids were seeded at a density of 2.3 ϫ 10 4 cells/cm 2 onto tissue culture-treated plasticware (Biofil or Nunc), pretreated with 0.2% fetal porcine gelatin (Sigma-Aldrich), in ES cell medium supplemented with 200 M L-proline (Sigma-Aldrich) and/or 5 or 20 mM amino acids (Sigma-Aldrich), as described in the text. Cells were cultured for 4 days with daily medium replenishment. Stock solutions of amino acids were made, according to manufacturer's suggestions, in DMEM or phosphate buffered saline (PBS), depending on the solubility of the amino acid. Stock solutions of aspartic acid and glutamic acid were made in 1 M HCl and buffered to pH 7 with NaOH immediately before addition to the medium. Images were taken on an Olympus IX51 with an F-view II digital camera (Olympus) and manipulated in Adobe Photoshop. Embryoid bodies (EBs) were formed from ES cells that had been cultured for 4 days in control or test medium, as described in the text. Cells were reduced to a single cell suspension with TryPLE Select (Life Technologies) and cultured at a density of 1 ϫ 10 5 cells/ml in nontissue culture-treated plasticware (Biofil) in differentiation medium (DMEM with high-glucose supplemented with 10% FCS, 0.1 mM ␤-mercaptoethanol, and penicillin/streptomycin). EBs were maintained and collected as described previously (63) .
Radioactive uptake assay. ES cells to be used in radioactive uptake assay were seeded at a density of 3.1 ϫ 10 4 cells/cm 2 in ES cell medium and cultured for 2 days, except when noted in the text. The uptake of radioactive L-proline and other nonradioactive amino acids was conducted essentially as described by Metzner and colleagues (55) . Cells were washed with PBS (Life Technologies) and 1 ml of uptake buffer [25 mM MES/Tris (pH 6) or 25 mM HEPES/Tris (pH 7.5), 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2, 0.8 mM MgSO4, and 5 mM glucose] supplemented with 0.5 Ci of L- [H 3 ]proline (GE Healthcare Life Sciences) in 50 or 200 M nonradioactive L-proline, as denoted in the text. Excess nonradioactive amino acids were added to the uptake buffer, as specified in the text; stock solutions of amino acids were made in H 2O or uptake buffer, depending on solubility of amino acids. Cells were incubated with radioactive L-proline for 10 min at 37°C or room temperature, as denoted in the text, after which radioactive L-proline was removed, and the cells were rapidly washed with fresh, ice-cold uptake buffer (without L- [H 3 ]proline) four times. Cells were lysed in 1 ml NaOH (0.5 M) for 2 min. Three milliliters of Ultima gold scintillation cocktail (PerkinElmer) and 1 ml of lysed solution were added into scintillation vials (PerkinElmer), and radioactivity was quantified with TRI-CARB 2100TR liquid scintillation counter (PerkinElmer) . To analyze the uptake of L-proline in the absence of Na ϩ , sodium chloride in the uptake buffer was replaced by 140 mM choline chloride. Gene expression analysis. For RT-PCR, total RNA was isolated from cells using TRIzol reagent (Invitrogen), as per the manufacturer's instructions, and was DNase I treated. cDNA synthesis was performed using M-MLV Reverse Transcriptase (Promega). PCR reactions, containing GoTaq Green Master Mix (Promega), 1 ng/l each of forward and reverse primers, and 1 l of cDNA, were initially heated to 95°C for 2 min and then cycled through 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s on a MJ Research or Bio-Rad thermocycler. Primer sequences, the number of cycles used for each primer pair, and the size of the expected amplicon are listed in Supplemental Table S2 .
Quantitative real-time PCR. RNA was isolated, DNase I treated, and cDNA was synthesized as for RT-PCR. Reactions, consisting of cDNA, absolute blue QPCR SYBR Green Mix (Thermo Scientific), with 200 nM each of forward and reverse primers, were amplified using MJ research thermocycler with a Chromo4 Continuous Fluorescence Detection System (MJ Research). The samples were initially heated to 95°C for 15 min, followed by 40 cycles of 95°C for 15 s, 60°C for 15 s, and 72°C for 30 s. The cycle threshold values for ␤-actin were normalized across samples, and the raw cycle threshold values were analyzed using Q-Gene software package (69) . Primer sequences are listed in Supplemental Table S2 .
Immunofluorescence. Cells to be analyzed were grown on gelatintreated glass coverslips in ES cell medium or 50% MEDII and fixed with ice-cold methanol. Fixed cells were permeabilized with PBS/ 0.25% Triton X-100 and blocked with 10% FCS. Antibodies directed against SNAT2 (Santa Cruz Biotechnology cat. no. sc-67081, 1:500) were applied in PBS-Triton X-100 with 1% FCS. An Alexaflour 488 conjugated anti-rabbit antibody (Life Technologies) was used at 1:1,000. Cells were mounted in Vectorshield with 4,6-diamidino-2-phenylindole (DAPI) to visualize the nucleus. Images were taken on an Olympus BX50 with an F-view II digital camera (Olympus) and manipulated in Adobe Photoshop.
Western blot. Total cellular protein was extracted from ES cells with 200 l Laemmli sample buffer (Bio-Rad) containing ␤-mercaptoethanol (Sigma-Aldrich) and protease inhibitor (no. P-8350; SigmaAldrich), as per the manufacturer's instructions. Protein extract was incubated at 100°C for 10 min and separated using a 10% SDS polyacrylamide gel. Standard immunoblot procedures were followed, and proteins were visualized using the Amersham ECL Plus blotting detection kit (GE Healthcare Life Sciences) and a Bio-rad ChemiDoc XRS, as per the manufacturer's instructions. Anti-SNAT2 antibody (Santa Cruz Biotechnology cat. no. sc-67081) was used at a 1:1,000 dilution. Anti-␤-tubulin antibody (Sigma-Aldrich) was used at 1:80,000 dilution.
Statistical analysis. Experiments were analyzed using an unpaired two-tailed Student's t-test, and significance was achieved at P Յ 0.05.
RESULTS

L-Proline is transported into ES cells.
The ability of glycine to prevent the MEDII-or L-proline-mediated differentiation of ES cells suggested that uptake of L-proline by the cell was required for activity (78) . The ability of ES cells to take up extracellular L-proline was investigated using competitive radioactive uptake assays. ES cells were incubated with 0.5 Ci L- [H 3 ]proline and increasing concentrations of L-proline (0 -10 mM; Fig. 1A ). In the absence of excess nonradioactive L-proline, ES cells retained radioactivity; in the presence of 1, 5, and 10 mM nonradioactive L-proline, radioactive retention was significantly reduced, suggesting that excess L-proline competed with L- [H 3 ]proline for cellular uptake. The rate of L-proline uptake in ES and EPL cells was found to be comparable (Fig. 1B) .
Amino acid transporters can be characterized by their pH and Na ϩ dependence (37). L-Proline uptake into ES cells is likely to involve several different transporters; work on other cells, however, suggests that there will be a transporter responsible for the majority of L-proline uptake. The uptake of
]proline into ES cells was measured at varying pH (pH 5 to pH 9). L- [H 3 ]proline uptake peaked at pH 7.5, with a significant reduction of activity observed at pH lower than pH 7 (Fig. 1C) . Similarly, the uptake of L- [H 3 ]proline by ES cells was measured in the presence and absence of Na ϩ . In the absence of Na ϩ , uptake of radioactivity by ES cells was reduced by ϳ60% (P Յ 0.05; Fig. 1D ), suggesting that the majority of L-proline transport was mediated by a Na ϩ -dependent transporter(s 
, was evaluated by RT-PCR in both ES and EPL cells (Fig. 2) . B 0,ϩ was included, as there is evidence in the literature that this transporter is present in the blastocyst (76) , but there is no evidence this transporter mediates L-proline uptake. Pat1 and Pat2 were included, as previous work had suggested Pat1 expression in ES cells (A. Lonic, unpublished observations). Snat1 was included as a previous report has suggested that this transporter transports L-proline (37) . ES cells and EPL cells, formed from ES cells cultured in 50% MEDII for 3 days, were analyzed with gene-specific primers at 25, 30, and 35 cycles. A band of the expected size and sequence was observed for Snat1, Snat2, Snat4, Pat1, and B 0 at2 in both ES and EPL cells (Fig. 2) . The lack of B 0 at1 transcripts in either cell type further refines the identity of the major L-proline transporter. Pat2 and B 0,ϩ were also not detected. 3 ]proline uptake in the presence of competing amino acids suggests SNAT2 is the major L-proline transporter on ES cells. The identity of the major L-proline transporter on ES cells was determined using competitive assays to identify potential transporter substrates; transporter identity can be deduced from the repertoire of amino acids transported (37) . ES cells were incubated with 0.5 Ci L- [H 3 ]proline, and an excess (5 mM) of nonradioactive amino acids and radioactive uptake into the cells was measured (Fig. 3A) . The control, the uptake of
L-[H
]proline into ES cells in the absence of excess amino acids, has been normalized to 1, and L- [H 3 ]proline uptake in all other conditions has been expressed relative to the control. Samples containing excess GABA, lysine, phenylalanine, valine, isoleucine, arginine, and tryptophan were not significantly different from the control (Fig. 3A) and were considered less likely to be substrates of the ES cell L-proline transporter. Amino acids that inhibited L- [H 3 ]proline uptake into ES cells were considered potential substrates of this transporter (Fig.  3A) . The suggested substrates of the ES cell L-proline transporter were similar to those observed for SNAT2 in other cell types, with L-proline uptake inhibited by amino acids consistently reported as substrates of SNAT2, cysteine, alanine, asparagine, methionine, histidine, serine, glutamine, proline, glycine, threonine, and the synthetic amino acid MeAIB (28,  52, 64, 70, 81 ). This profile of substrates is distinct from the substrates transported by SNAT1 (uptake was inhibited by excess proline) (52, 77) , SNAT4 (uptake was inhibited by MeAIB, glutamine, and threonine) (27, 71) , PAT1 (uptake was not inhibited by GABA) (8, 65, 79) , and B 0 AT2 (uptake was not inhibited by leucine, valine, isoleucine, or phenylalanine) (11, 73) . L-Proline uptake in D3 ES cells under different conditions, in a second ES cell line, CGR8, and in EPL cells (Supplemental Fig. S1 ) showed similar characteristics to D3 ES cells in Fig. 3 . L-Proline transport into ES cells was affected by the presence of aspartic acid and glutamic acid, amino acids that have not been suggested as substrates of SNAT2. There has been no transporter reported with a substrate portfolio, including L-proline and the anionic amino acids ( Table 1) , suggesting that the reduction of L-proline uptake into ES cells in the presence of these amino acids is unlikely to be reflecting the biology of a transporter, but may arise from the effect of these amino acids on the transport environment.
Western blot and immunofluorescence were used to confirm the presence of SNAT2 in ES and EPL cells. By Western blot, a protein of the expected size was detected in ES cells with an antibody raised to SNAT2 (Fig. 3B) . Similarly, immunofluorescence using the same antibody detected protein at the cell periphery and within the perinuclear space, a distribution pattern consistent with that already reported for SNAT2 (Fig.   3C ) (26) . Protein was detected in all the cells, including cells with an overtly pluripotent cell morphology and spontaneously differentiated cells within the culture (Fig. 3C, data not  shown) .
Competitors of L-proline uptake into ES cells prevent cell differentiation. The formation of EPL cells is accompanied by a distinct change in morphology and gene expression (61, 78) . ES cells were cultured in ES cell medium, with or without 200 M L-proline and 5 mM of L-alanine, L-asparagine, glycine, L-glutamine, L-serine, or MeAIB (SNAT2 substrates), L-lysine, L-valine, or GABA (nonsubstrates of SNAT2), or the anionic amino acids aspartic acid and glutamic acid, for 4 days, and analyzed by morphology and for the expression of the pluripotent marker Oct4, the ES cell markers Rex1 and Spp1, and the EPL cell markers Dnmt3b and Otx2 (32, 59, 61, 78) . In the presence of any of these amino acids and without L-proline, ES cells maintained an ES cell-like colony morphology and gene expression (data not shown; Supplemental Fig. S2 ), suggesting that none of these amino acids were able to induce ES cell differentiation. When cultured with L-proline and L-lysine, L-valine, or GABA, ES cells adopted an EPL cell-like colony morphology (Fig. 4, A-F ; data not shown) and a gene expression profile (Fig. 4G) , consistent with cells cultured in L-proline alone, suggesting that these amino acids were not able to (Fig. 4G) . This is in contrast to the apparent ability of these amino acids to prevent the transport of L-proline into the cells and suggests that the inhibition of transient uptake is not sustained in culture. When cells were cultured in L-proline and alanine, asparagine, glycine, serine, or MeAIB, they maintained an ES cell-like colony morphology (Fig. 4, A-F ; data not shown) and gene expression (Fig. 4G) , suggesting that the addition of these amino acids prevented the differentiation of ES cells in response to L-proline. The ability of an amino acid to inhibit L-proline activity and ability to be transported by SNAT2 aligned. Amino acids unable to inhibit L-proline activity are substrates of PAT1 (GABA) or B 0 AT2 (L-valine). Moreover, MeAIB, a synthetic amino acid that inhibits SNAT2 is not a substrate of SNAT4.
The addition of 5 mM L-glutamine did not appear to prevent ES cell differentiation in response to L-proline, despite being a substrate of SNAT2 and able to modulate L-proline uptake in ES cells (Supplemental Fig. S3 ). L-Glutamine is renowned for being unstable in culture, and the addition of 5 mM L-glutamine did not maintain a consistent concentration of glutamine in the medium (Supplemental Fig. S3E) . Alternatively, even though we did not add any additional L-glutamine to our medium, L-glutamine is present in DMEM at 4 mM, raising the possibility that the cells have adapted in culture to high levels of this amino acid. ES cells were cultured in ES cell medium supplemented with L-proline and 20 mM L-glutamine. At this concentration, L-glutamine, like glycine, prevented acquisition of EPL cell-like colony morphology or gene expression (Supplemental Fig. S3, A-C, F) . The addition of 20 mM arginine or valine did not prevent differentiation by L-proline, suggesting that the presence of 20 mM amino acid alone was not able to alter the ability of the cells to respond to L-proline (Supplemental Fig. S3F) .
Previous studies have shown that primitive ectoderm-like cells formed in response to MEDII or L-proline show distinct differentiation kinetics compared with ES cells (46, 78) . Cells cultured in MEDII or L-proline before differentiation within EBs show more rapid differentiation, with upregulation of the primitive streak markers, including brachyury, on days 2 and 3 of EB differentiation, compared with untreated ES cells, which upregulate primitive streak markers on day 4 or later. ES cells cultured for 4 days in 5 mM L-alanine, MeAIB (SNAT2 substrates), L-lysine, or GABA (nonsubstrates of SNAT2), with or without L-proline, were differentiated as EBs and analyzed on day 3 for the expression of brachyury (T) (Fig. 5) . ]proline in the absence of sodium, varying pH, and in the presence of other amino acids (28, 52, 64, 70, 81) is consistent with the transporter SNAT2 playing a major role in the transport of L-proline into ES and EPL cells in culture. L-Proline uptake into ES and EPL cells was consistently competed by amino acids that had been previously identified as substrates of the SNAT2 transporter, and not by amino acids that had been identified as substrates of other potential transporters [PAT1 (GABA) or B 0 AT2 (L-leucine, L-valine, L-isoleucine and Lphenylalanine)]. SNAT1 and SNAT4 are reported to transport similar amino acids to SNAT2 and are difficult to distinguish biochemically. SNAT1 is a major glutamine transporter (52, 77) . L-Proline has been suggested to be a substrate of SNAT1 (37) , but this is not consistent with other reports that suggest L-proline is a poor substrate of this transporter (52, 77) . SNAT4 does not transport MeAIB and glutamine (27, 71) . MeAIB inhibited proline uptake in the cells tested, and glutamine affected proline uptake at higher concentrations. These data suggest that L-proline uptake by SNAT1 and SNAT4 will be low compared with SNAT2 and are consistent with the suggested role for SNAT2 in L-proline uptake by ES cells in culture.
Comparison of ES cell-derived EBs with EBs derived from ES
SNAT2, also known as amino acid transporter A2 or system A amino acid transporter 2 and encoded by Slc38a2, is a member of the system A class of amino acid transporter family, a near ubiquitously expressed group of Na ϩ -dependent amino acid transporters that actively transport small, zwitterionic, neutral amino acids with short, unbranched side chains and with the unique ability to transport N-methylated amino acids, such as MeAIB (28, 52, 64, 70, 81) . Unlike many amino acid transporters, analysis of SNAT2 activity suggests that it is regulated within the cell and, in turn, is able to regulate cellular functions (17, 25, 26, 34 -36, 39) . Moreover, it has been suggested that SNAT2 works as a transceptor, with the potential to transport and detect intracellular and extracellular amino acid levels (9, 33, 35) . SNAT2 protein is stored in the perinuclear space of both muscle and adipose cells; at times of amino acid deficiency, transport of SNAT2 to the plasma membrane is accelerated, providing an immediate response to nutritional stress (26, 34, 36) . This provides the cell with a supply of transporter to ensure uptake of amino acids from the extracellular environment. In ES and EPL cells, immunolocalization of SNAT2 detected areas of intense fluorescence adjacent to the nucleus, consistent with the presence of SNAT2 storage in the perinuclear space, as well as diffuse staining, consistent with SNAT2 on the cell surface. Gene expression confirmed SNAT2 transcripts in ES and EPL cells, but also detected the presence of several other L-proline transporters: SNAT1, SNAT4, PAT1, and B 0 AT2. The presence of these transporters potentially accounts for the residual L- [H 3 ]proline uptake seen in cells incubated with inhibitory amino acids.
The addition of L-proline to ES cells induces differentiation toward an EPL cell (78) . Previous work has shown that the ability of L-proline to induce differentiation was inhibited by the addition of a molar excess of glycine, an observation compatible with a role for L-proline transport and an amino acid transporter in differentiation (78) . The correlation of L-proline uptake and activity described here shows that SNAT2 substrates, L-alanine, L-asparigine, L-glycine, L-serine, and MeAIB, that inhibit uptake of L-proline in uptake assays prevented ES cells from adopting EPL cell-like colony morphology and gene expression in response to L-proline. Other amino acids, such as GABA, L-valine, and L-lysine, which have not been identified as substrates of SNAT2, had no effect on EPL cell formation. The fact that these amino acids are substrates of SNAT2, PAT1, or B 0 AT2 suggests that these transporters are not mediating the activity of L-proline in ES cell differentiation. Furthermore, the ability of MeAIB to prevent activity is not consistent with a role for SNAT4 in L-proline uptake. These data suggest that L-proline uptake via SNAT2 mediates the biological activity of L-proline on ES cells.
The biological activity of L-proline suggests that L-proline transport and uptake by SNAT2 alters gene expression within ES cells. The role of SNAT2 in ES cell differentiation in response to L-proline could be to increase the intracellular concentration of L-proline and promote activation of an intracellular sensor and intracellular signaling pathways, or through the interaction of L-proline with SNAT2, resulting in an intracellular signaling cascade initiated by SNAT2. To date, two established intracellular signaling pathways have been implicated in the monitoring and response to amino acid availability: the AAR pathway (41, 42) and mTOR (4, 49) . Limitations in amino acids trigger the AAR pathway, activating general control nonderepressible protein 2 and upregulation of activating transcription factor 4 expression (1, 2, 23 ). The amino acid sensor, mTOR, consists of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) (22, 43, 51) . RAG proteins have recently been shown to interact with amino acids to facilitate mTORC1 regulation (44, 66) . Alternatively, a type III phosphatidylinositol 3-kinase vps34 interacts with amino acids and initiates downstream signaling from mTOR (12, 58) . The existence of intracellular amino acid sensors capable of regulating downstream transcription suggests that variation of the intracellular concentration of L-proline could regulate ES cell gene expression. Our laboratory has already shown the L-proline activity requires that activation of mTOR; mTOR activation is required but not sufficient for ES cell differentiation, suggesting the activation of multiple intracellular pathways by L-proline and/or SNAT2 (78) .
Amino acids in embryo development. Roles for amino acids and amino acid signaling in early mammalian development have been well documented. During embryo culture, the modulation of amino acids in the culture medium improves culture outcomes. The addition of nonessential amino acids and glutamine has been shown to increase blastocyst formation and hatching rate (48) , whereas removal of nonessential amino acids resulted in significantly more embryos arresting at the two-cell stage (20) . After the eight-cell stage, the embryo requires essential, but not nonessential, amino acids for development in culture (47) .
Characterization of the amino acid transporters and transporter activity present in the early embryo has revealed complex and dynamic expression of these proteins. The betaine/ proline transporter IMINO (also known as SIT1) is active at the one-and two-cell stages of the embryo (3). The transience of IMINO activity is consistent with this transporter playing an important and specific function in preimplantation development. The amino acid transporter system B 0,ϩ is present in the blastocyst; transport of leucine through this transporter has been shown to regulate trophoblast mobility and the penetration stage of implantation through activation of mTOR (54, 76). Like IMINO, the activity of B 0,ϩ is transient: the transporter becomes inactive a few hours before implantation (76) and is reactivated as the trophoblast penetrates the uterine wall. We were unable to detect the expression of B 0,ϩ in mouse ES cells, suggesting that the expression of this transporter is restricted to the trophectoderm or that ES cells represent pluripotent cells present after the downregulation of the transporter. Finally, characterization of amino acid concentrations in follicular fluid has shown several amino acids, including L-alanine and glycine, to be at high concentrations compared with blood plasma, raising the possibility of competitive control of amino acid transport into the embryo as a mechanism for regulating embryo development (24, 31) . The modulation of transporters during preimplantation development and high levels of amino acids in the follicular fluid suggest that aspects of embryo development and function may be regulated maternally through regulation of amino acid transporter activity.
The characterization of amino acid transporters in early mammalian embryos is limited, and there is little known of mechanisms used for the transport of L-proline at any stage. The formation of EPL cells in culture provides an excellent model of primitive ectoderm formation in the embryo (62, 63) ; analysis of this system suggests that the ICM and primitive ectoderm will use SNAT2 as their primary L-proline transporter. This is consistent with previous experiments that identified system A transporters as the major transport system in the ICM (38) .
Amino acids as a route to improved conditions for pluripotent cells in culture. Analysis of mouse and human ES cell cultures has revealed a high degree of cellular heterogeneity within apparently homogenous populations (30, 50, 75) . Dissection of the populations present in mouse ES cells suggested that these cells comprised a mix of ICM-like, epiblast-like, and primitive ectoderm-like cells (75) . Similarly, human ES cells were shown to form a continuum from pluripotent cells to cells that appeared primed to differentiate to specific cell lineages (30) . Heterogeneity will impact on the purity of differentiation outcomes that can be achieved from pluripotent cells as subpopulations of cells within the population can respond differently to inductive signals. Overcoming heterogeneity and defining growth conditions for pluripotent cells that lead to more homogenous populations of either ICM or primitive ectodermlike cells is a continuing goal of the field. It has been suggested that heterogeneity arises from activation of extrinsic signaling pathways that are upstream to transcription factor networks in the cell. The data presented here suggest that one possible route to intracellular signaling pathway activation is through the amino acid composition of the culture medium. Medium formulations permissive to L-proline uptake, through inclusion of L-proline without other amino acids able to prevent SNAT2 uptake of L-proline, could result in mixed populations comprising ICM-like, epiblast-like, and primitive ectoderm-like cells, similar to those seen by Toyooka and colleagues (75) . It is of note that L-proline is a regular addition to many pluripotent cell medium formulations. The data reported here provide a number of specific and inexpensive culture additives that can regulate SNAT2 transporter activity and L-proline uptake and have the potential to impact on the complexity of pluripotent cell populations in culture.
Conclusions. This is the first study that characterizes the involvement of an amino acid transporter in ES cell differentiation. The ability to modulate L-proline uptake and SNAT2 activity through the addition of exogenous amino acids defines specific and inexpensive culture supplements with potential applications in improving the maintenance, or differentiation, of pluripotent cells in the future. Furthermore, this work describes a novel and amenable model to investigate amino acid regulation of intracellular signaling, transcriptional activity, and cellular function.
